common side effects of veletri
agitation
anxiety
chest pain
headache
hypotension
nausea
nervousness
vomiting
flushing
other side effects
abdominal pain
bradycardia
dizziness
comprehensive list of adverse effects
needed effects
epoprostenol
active ingredient
veletri
unwanted side effects
medical attention
following side effects
taking epoprostenol
check
doctor
epoprostenol side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
adverse effects
epoprostenol
active ingredient
veletri
symptoms of primary pulmonary hypertension
adverse effects
disease state
dyspnea
fatigue
chest pain
right ventricular failure
pallor
side effects
drug
headache
jaw pain
flushing
diarrhea
nausea
vomiting
flu-like symptoms
anxiety
cardiovascular
side effects
flushing
patients
hypotension
side effects
acute dose-ranging phase of epoprostenol
active ingredient
veletri
administration
effects
potent vasodilation
chest pain
bradycardia
tachycardia
acute dosing
adverse cardiovascular events
chronic infusions
tachycardia
flushing
fatal cerebral edema
bugiardini
colleagues
epoprostenol at therapeutic doses
induced myocardial ischemia
angina
st segment depression
lactate consumption
patients with advanced coronary artery disease
mechanism
maldistribution of blood flow
counteraction of ischemia
aminophylline
antiarrhythmic effects
study
epoprostenol infusion
induction of atrial
ventricular arrhythmias
atrial
av
nodal conduction times
increase in adrenergic tone
davenport
colleagues
patients
receiving direct femoral infusions of epoprostenol
ng/kg/min
minutes
hemodialysis
extracorporeal clotting
patients
fulminant hepatic failure
acute renal failure
acetaminophen self-poisoning
mean
arterial pressure
cerebral perfusion pressure
arterial oxygen pressure
intracranial pressure
cardiac output
patients
cerebral edema
authors
epoprostenol
infusion port on the extracorporeal circuit
patients with hepatic
renal failure
requiring hemodialysis
changes in cerebral perfusion pressure
oxygen delivery
zusman
colleagues
epoprostenol at ng/kg/min
ng/kg/min
ng/kg/min lead
increased adverse effects in patients with chronic renal failure
undergoing hemodialysis anticoagulation
hypotension
primary adverse cardiovascular event
requiring discontinuation of the higher dosage
hemodynamic changes
decreased blood pressure
heart rate
patients with chronic renal failure
increased hemodynamic sensitivity
higher basal plasma prostaglandin levels
nervous system
side effects
reports of headache
vasodilation
patients during acute dose
patients during chronic dosing
anxiety
nervousness
agitation
patients
dizziness
patients during acute phase dose
anxiety
nervousness
tremor
patients during the chronic phase
dose-ranging studies headache
dose-limiting side effect
zusman
colleagues
epoprostenol
active ingredient
veletri
ng/kg/min
ng/kg/min
ng/kg/min lead
increased adverse effects in patients with chronic renal failure
undergoing hemodialysis anticoagulation
nausea
vomiting
primary adverse gastrointestinal events
requiring discontinuation of the higher dosage
gastrointestinal side effects
reports of nausea
vomiting
patients during the acute dose
ranging phase
patients during chronic dosing
dyspepsia
abdominal pain
patients during acute dosing
diarrhea
patients during the chronic phase
musculoskeletal side effects
rare reports
pain
musculoskeletal pain during acute dosing
chronic phase
jaw pain
myalgia
general musculoskeletal pain
other side effects
reports of jaw pain
patients on chronic infusions
chills
fever
sepsis
flu-like symptoms
patients
ascites
pleural effusions
adverse effects
mechanical problems with the infusion pump
tachyphylaxis
increased requirement for epoprostenol
active ingredient
veletri
time
tolerance
drug
disease progression
doses of epoprostenol
barst et al
patients
mechanical problems
including pump malfunction
problems with syringe
tubing
catheter systems
epoprostenol
problems
patients
increased pulmonary hypertension symptoms
including syncope
episode
clotting
times in patients
episode
resulting in sepsis
jones
colleagues
occurrence of sterile ascites in patients during long-term epoprostenol treatment
protein content
aspartate aminotransferases levels
patients
ascites
death
patient
ascites
pale yellow appearance
hematologic side effects
reports of sepsis
infections from the
indwelling catheter tip
thrombocytopenia
uncontrolled clinical trials
significant bleeding
thrombocytopenia
barst
colleagues
episodes of nonfatal sepsis
catheter tips
patients
receiving epoprostenol for primary pulmonary hypertension
patient
sepsis after a thrombus
catheter
jones
colleagues
patients
septicemia
catheter tip infections
case
subjective wellbeing
exercise capacity
antibiotics
patient
peripheral line
infection
endocrine side effects
rare reports of sweating during acute dosing
respiratory side effects
rare report of dyspnea during acute dosing
additional side effects
hypoxia
pulmonary edema
local side effects
injection site pain
local infection
peripheral venous local reactions
bright red veins
induration
tenderness
epoprostenol infusion
minutes after discontinuation of the infusion
high ph of the buffer
psychiatric side effects
reports of depression
psychiatric side effects
reports of depression in women
receiving epoprostenol infusions for raynaud
phenomenon
systemic sclerosis
antidepressant therapy
several cases
ocular side effects
reports of photosensitivity
dermatologic side effects
rash
side effects of veletri
fda
healthcare professional for medical advice
stomach pain
arm
jaw pain
bladder pain
bleeding gums
bloating
swelling of the face
arms
hands
lower legs
feet
cloudy urine
blurred vision
changes in skin color
chest congestion
chest pain
discomfort
chest tightness
heaviness
chills
cold hands
feet
confusion
constipation
convulsions
cough or hoarseness
coughing up blood
decreased urine
depression
diarrhea
burning
painful urination
difficulty with breathing
swallowing
dilated neck veins
dizziness
faintness
lightheadedness
getting
lying
sitting position
dry mouth
extreme fatigue
pounding
irregular heartbeat
pulse
feeling of warmth
fever
headache
incoherent speech
increased menstrual flow
vaginal bleeding
increased thirst
increased urination
local infection at the catheter site
loss of appetite
metallic taste
muscle pain
cramps
muscle weakness
nausea or vomiting
nosebleeds
numbness
tingling in the hands
feet
lips
pain at the injection site
pain
redness
swelling in the arm
leg
paleness of the skin
prolonged bleeding from cuts
rapid weight gain
tarry stools
redness of the face
neck
arms
upper chest
sweating
swelling of the face
fingers
feet
lower legs
tightness in the chest
tingling of the hands
feet
unusual tiredness
weakness
weight gain
loss
abnormal touch sensation
sensitivity
blue lips
fingernails
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
coughing
pink frothy sputum
noisy breathing
inability to speak
increased sweating
numbness
tingling in the hands
feet
lips
pain
discomfort in the arms
jaw
neck
seizures
sudden headache
severe pain in the chest
slurred speech
sudden onset of severe breathing
temporary blindness
weakness in the arm
leg
side of the body
weakness
heaviness of the legs
feeling of fullness
high fever
red spots on the skin
sensitivity to heat
sores
ulcers
white spots on the lips
mouth
swollen glands
trouble sleeping
troubled breathing with exertion
change in vision
difficulty
bowel movement
stool
difficulty with moving
heartburn
hives or welts
impaired vision
itching
joint pain
lack of appetite
lack
loss of strength
loss of interest
pleasure
muscle pains
stiffness
redness of the skin
shakiness in the legs
arms
hands
feet
skin rash
oozing
sores on the skin
swollen joints
tiredness
trembling
shaking of the hands
feet
trouble concentrating
acid
sour stomach
belching
blurred vision
other changes in vision
excess air
gas in the stomach
intestines
indigestion
leg cramps
passing gas
sleepiness
unusual drowsiness
stomach discomfort
upset